Deceased-donor kidney perfusate and urine biomarkers for kidney allograft outcomes: A systematic review

Ronik S. Bhangoo, Isaac E. Hall, Peter P. Reese, Chirag Parikh

Research output: Contribution to journalArticle

Abstract

Background. Accurate and reliable assessment of kidney quality before transplantation is needed to predict recipient outcomes and to optimize management and allocation of the allograft. The aim of this study was to systematically review the published literature on biomarkers in two mediums (the perfusate from deceased-donor kidneys receiving machine perfusion and deceased-donor urine) that were evaluated for their possible association with outcomes after kidney transplantation. Methods. We searched the Ovid Medline and Scopus databases using broad keywords related to deceased-donor biomarkers in kidney transplantation (limited to humans and the English language). Studies were included if they involved deceased-donor kidneys, measured perfusate or urine biomarkers and studied a possible relationship between biomarker concentrations and kidney allograft outcomes. Each included article was assessed for methodological quality. Results. Of 1430 abstracts screened, 29 studies met the inclusion criteria. Of these, 23 were studies of perfusate (16 biomarkers examined) and 6 were studies of urine (18 biomarkers examined). Only 3 studies (two perfusate) met the criteria of 'good' quality and only 12 were published since 2000. Perfusate lactate dehydrogenase, glutathione-S-transferase (GST) and aspartate transaminase were all found to be significantly associated with delayed graft function in a majority of their respective studies (6/9, 4/6 and 2/2 studies, respectively). Urine neutrophil gelatinase-associated lipocalin, GST, Trolox-equivalent antioxidant capacity and kidney injury molecule-1 were found to be significantly associated with allograft outcomes in single studies that examined diverse end points. Conclusion. Higher quality studies are needed to investigate modern kidney injury biomarkers, to validate novel biomarkers in larger donor populations and to determine the incremental predictive value of biomarkers over traditional clinical variables. Published by Oxford University Press on behalf of ERA-EDTA 2012. 2012

Original languageEnglish (US)
Pages (from-to)3305-3314
Number of pages10
JournalNephrology Dialysis Transplantation
Volume27
Issue number8
DOIs
StatePublished - Aug 1 2012

Fingerprint

Allografts
Biomarkers
Urine
Kidney
Glutathione Transferase
Kidney Transplantation
Delayed Graft Function
Wounds and Injuries
Aspartate Aminotransferases
L-Lactate Dehydrogenase
Edetic Acid
Language
Perfusion
Antioxidants
Transplantation
Databases
Population

Keywords

  • biomarkers
  • deceased donors
  • delayed graft function
  • kidney transplantation

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Deceased-donor kidney perfusate and urine biomarkers for kidney allograft outcomes : A systematic review. / Bhangoo, Ronik S.; Hall, Isaac E.; Reese, Peter P.; Parikh, Chirag.

In: Nephrology Dialysis Transplantation, Vol. 27, No. 8, 01.08.2012, p. 3305-3314.

Research output: Contribution to journalArticle

@article{921142a045a44eff9cd7e03f59bcbda2,
title = "Deceased-donor kidney perfusate and urine biomarkers for kidney allograft outcomes: A systematic review",
abstract = "Background. Accurate and reliable assessment of kidney quality before transplantation is needed to predict recipient outcomes and to optimize management and allocation of the allograft. The aim of this study was to systematically review the published literature on biomarkers in two mediums (the perfusate from deceased-donor kidneys receiving machine perfusion and deceased-donor urine) that were evaluated for their possible association with outcomes after kidney transplantation. Methods. We searched the Ovid Medline and Scopus databases using broad keywords related to deceased-donor biomarkers in kidney transplantation (limited to humans and the English language). Studies were included if they involved deceased-donor kidneys, measured perfusate or urine biomarkers and studied a possible relationship between biomarker concentrations and kidney allograft outcomes. Each included article was assessed for methodological quality. Results. Of 1430 abstracts screened, 29 studies met the inclusion criteria. Of these, 23 were studies of perfusate (16 biomarkers examined) and 6 were studies of urine (18 biomarkers examined). Only 3 studies (two perfusate) met the criteria of 'good' quality and only 12 were published since 2000. Perfusate lactate dehydrogenase, glutathione-S-transferase (GST) and aspartate transaminase were all found to be significantly associated with delayed graft function in a majority of their respective studies (6/9, 4/6 and 2/2 studies, respectively). Urine neutrophil gelatinase-associated lipocalin, GST, Trolox-equivalent antioxidant capacity and kidney injury molecule-1 were found to be significantly associated with allograft outcomes in single studies that examined diverse end points. Conclusion. Higher quality studies are needed to investigate modern kidney injury biomarkers, to validate novel biomarkers in larger donor populations and to determine the incremental predictive value of biomarkers over traditional clinical variables. Published by Oxford University Press on behalf of ERA-EDTA 2012. 2012",
keywords = "biomarkers, deceased donors, delayed graft function, kidney transplantation",
author = "Bhangoo, {Ronik S.} and Hall, {Isaac E.} and Reese, {Peter P.} and Chirag Parikh",
year = "2012",
month = "8",
day = "1",
doi = "10.1093/ndt/gfr806",
language = "English (US)",
volume = "27",
pages = "3305--3314",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Deceased-donor kidney perfusate and urine biomarkers for kidney allograft outcomes

T2 - A systematic review

AU - Bhangoo, Ronik S.

AU - Hall, Isaac E.

AU - Reese, Peter P.

AU - Parikh, Chirag

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Background. Accurate and reliable assessment of kidney quality before transplantation is needed to predict recipient outcomes and to optimize management and allocation of the allograft. The aim of this study was to systematically review the published literature on biomarkers in two mediums (the perfusate from deceased-donor kidneys receiving machine perfusion and deceased-donor urine) that were evaluated for their possible association with outcomes after kidney transplantation. Methods. We searched the Ovid Medline and Scopus databases using broad keywords related to deceased-donor biomarkers in kidney transplantation (limited to humans and the English language). Studies were included if they involved deceased-donor kidneys, measured perfusate or urine biomarkers and studied a possible relationship between biomarker concentrations and kidney allograft outcomes. Each included article was assessed for methodological quality. Results. Of 1430 abstracts screened, 29 studies met the inclusion criteria. Of these, 23 were studies of perfusate (16 biomarkers examined) and 6 were studies of urine (18 biomarkers examined). Only 3 studies (two perfusate) met the criteria of 'good' quality and only 12 were published since 2000. Perfusate lactate dehydrogenase, glutathione-S-transferase (GST) and aspartate transaminase were all found to be significantly associated with delayed graft function in a majority of their respective studies (6/9, 4/6 and 2/2 studies, respectively). Urine neutrophil gelatinase-associated lipocalin, GST, Trolox-equivalent antioxidant capacity and kidney injury molecule-1 were found to be significantly associated with allograft outcomes in single studies that examined diverse end points. Conclusion. Higher quality studies are needed to investigate modern kidney injury biomarkers, to validate novel biomarkers in larger donor populations and to determine the incremental predictive value of biomarkers over traditional clinical variables. Published by Oxford University Press on behalf of ERA-EDTA 2012. 2012

AB - Background. Accurate and reliable assessment of kidney quality before transplantation is needed to predict recipient outcomes and to optimize management and allocation of the allograft. The aim of this study was to systematically review the published literature on biomarkers in two mediums (the perfusate from deceased-donor kidneys receiving machine perfusion and deceased-donor urine) that were evaluated for their possible association with outcomes after kidney transplantation. Methods. We searched the Ovid Medline and Scopus databases using broad keywords related to deceased-donor biomarkers in kidney transplantation (limited to humans and the English language). Studies were included if they involved deceased-donor kidneys, measured perfusate or urine biomarkers and studied a possible relationship between biomarker concentrations and kidney allograft outcomes. Each included article was assessed for methodological quality. Results. Of 1430 abstracts screened, 29 studies met the inclusion criteria. Of these, 23 were studies of perfusate (16 biomarkers examined) and 6 were studies of urine (18 biomarkers examined). Only 3 studies (two perfusate) met the criteria of 'good' quality and only 12 were published since 2000. Perfusate lactate dehydrogenase, glutathione-S-transferase (GST) and aspartate transaminase were all found to be significantly associated with delayed graft function in a majority of their respective studies (6/9, 4/6 and 2/2 studies, respectively). Urine neutrophil gelatinase-associated lipocalin, GST, Trolox-equivalent antioxidant capacity and kidney injury molecule-1 were found to be significantly associated with allograft outcomes in single studies that examined diverse end points. Conclusion. Higher quality studies are needed to investigate modern kidney injury biomarkers, to validate novel biomarkers in larger donor populations and to determine the incremental predictive value of biomarkers over traditional clinical variables. Published by Oxford University Press on behalf of ERA-EDTA 2012. 2012

KW - biomarkers

KW - deceased donors

KW - delayed graft function

KW - kidney transplantation

UR - http://www.scopus.com/inward/record.url?scp=84864614153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864614153&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfr806

DO - 10.1093/ndt/gfr806

M3 - Article

C2 - 22498916

AN - SCOPUS:84864614153

VL - 27

SP - 3305

EP - 3314

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 8

ER -